Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

BioMed Realty, L.P. Prices $250 Mln Senior Notes Offering

RELATED NEWS
Trade BMR now with 
6/21/2012 4:06 PM ET

BioMed Realty Trust, Inc. (BMR: Quote) said Thursday that its operating partnership subsidiary, BioMed Realty, L.P., priced a public offering of $250 million aggregate principal amount of 4.25% Senior Notes due 2022.

The Notes were priced at 99.126% of the principal amount to yield 4.358% to maturity.

The operating partnership plans to use the net proceeds from the offering to repay a portion of the outstanding indebtedness under its unsecured line of credit and for other general corporate and working capital purposes.

Click here to receive FREE breaking news email alerts for BioMed Realty Trust and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With traders digesting remarks from Federal Reserve Chairman Ben Bernanke, stocks have seen considerable volatility over the course of the trading day on Wednesday but are moving mostly higher in mid-day trading. The major averages have moved to the upside in recent trading and are currently posting notable gains. Comprehensive immigration reform legislation took a step toward approval on Tuesday, as the members of the Senate Judiciary Committee voted to send the bill to the Senate floor. The Senate Judiciary Committee voted 13 to 5 in favor of the bill, with three Republicans joining with the panel's ten Democrats in voting to support the legislation. Existing home sales in the U.S. saw a modest increase in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales climbed 0.6 percent to a seasonally adjusted annual rate of 4.97 million in April from an upwardly revised 4.94 million in March.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.